1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Cytrabine: new trials by email Literature Review of Cytrabine trials Research Report on Cytrabine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients Revumenib, Cytrabine, Daunorubicin - Pediatric Acute Leukemia | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2026-05-21 | 2026-09-23 |
M.D. Anderson Cancer Center (1)